Bruker vs Globus Medical

Bruker (BRKR), health care, and Globus Medical (GMED), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Bruker and Globus Medical are valued at about the same: $9.4B and $9.3B. Bruker's operating margin in its latest fiscal year was 1.98% and Globus Medical's 16.3%. Over the past year Bruker's share price has moved +42.1% and Globus Medical's -15.5%.

Key facts

Bruker market value
$9.4B
Globus Medical market value
$9.3B
Globus Medical P/E
17.4
Bruker revenue
$3.4BFY to 2025-12-31
Globus Medical revenue
$2.9BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Bruker vs Globus Medical: every measure side by side
Measure Bruker Globus Medical
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$9.4Bhigher$9.3Blower
Revenue$3.4Bhigher$2.9Blower
Earnings-$8.6Mlower$537.9Mhigher
Employees11,085higher6,000lower
Total assets$6.2Bhigher$5.3Blower
Valuation
P/E—17.4
P/S2.7lower3.2higher
P/B4.1higher1.9lower
Dividend yield0.08%higher0.00%lower
Profitability
Operating margin1.98%lower16.3%higher
Balance sheet
Net assets$2.5Blower$4.6Bhigher
Total liabilities$3.7Bhigher$729.5Mlower
Total debt$1.9B—
Cash on hand$298.8Mlower$526.2Mhigher
Price change
Today+1.22%higher-0.72%lower
1 year+42.1%higher-15.5%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Globus Medical only (2)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Bruker / Globus Medical). Who owns BRKR · Who owns GMED

Further comparisons

Learn

Questions and answers

Which is bigger, Bruker or Globus Medical?

By market value, Bruker is the larger: $9.4B against $9.3B for Globus Medical. By revenue in its latest fiscal year, Bruker is the larger: $3.4B against $2.9B for Globus Medical.

Which has the higher operating margin?

Globus Medical: 16.3%, against 1.98% for Bruker. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Bruker: 0.08%, against 0.00% for Globus Medical. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Bruker and Globus Medical?

In their latest 13F filings, Jeremy Grantham (co-founder) holds both.

Cite this page

Funkfolio, “Bruker vs Globus Medical”, data as of 18 November 2026. https://funkfolio.com/compare/brkr-vs-gmed

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.